| 000 | 01637 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515061402.0 | ||
| 264 | 0 | _c20070515 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a0959-4493 | ||
| 024 | 7 |
_a10.1111/j.1365-3164.2007.00576.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBäumer, Wolfgang | |
| 245 | 0 | 0 |
_aEffects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes. _h[electronic resource] |
| 260 |
_bVeterinary dermatology _cApr 2007 |
||
| 300 |
_a107-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarboxylic Acids _xpharmacology |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 4 |
| 650 | 0 | 4 | _aCyclohexanecarboxylic Acids |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aDermatitis, Atopic _xdrug therapy |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aSpecies Specificity |
| 700 | 1 | _aKietzmann, Manfred | |
| 773 | 0 |
_tVeterinary dermatology _gvol. 18 _gno. 2 _gp. 107-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-3164.2007.00576.x _zAvailable from publisher's website |
| 999 |
_c16911417 _d16911417 |
||